This special report focuses on the growing health crisis among seemingly fit individuals, highlighted by the recent mild stroke suffered by Zerodha's CEO, Nithin Kamath. He admitted, 'I made the ...

Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after onset) – a population with no approved drug options. Scp776 was safe and ...

Following an acute ischemic stroke, the risk of recurrent stroke is highest in the first 90 days. It is unclear whether this risk is altered by reperfusion therapy. In this meta-analysis, we aim to ...